1. Human Supplementation and Circulating C15:0
In a 12-week double-blind randomized trial, 30 young adults with overweight or obesity received 200 mg C15:0 daily or placebo. Supplementation significantly increased circulating C15:0 and no significant adverse events occurred. Exploratory clinical-index changes were associated with achieved blood levels and require confirmation in larger trials.
Citation: Robinson et al., Journal of Nutrition 154 (2024), 2763–2771. DOI: 10.1016/j.tjnut.2024.07.030.View source









